BPIQ Blog

Feb 20, 20231 min read

Biotech Catalyst Watchlist Q1 2023

Lot's of catalysts still coming Q1 2023, see more details and Catalyst Calendar below... 💬 Connect with us and fellow traders → in our...

Feb 19, 20231 min read

Weekly Biotech Catalyst Watchlist Feb 2023

Lot's of catalysts still coming in February, more details below... Last week hedge funds had to report their Q4 holdings, we analyzed 35+...

Feb 17, 20231 min read

Biopharma Pulse - 2/13-2/17 Weekly Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Feb 16, 20231 min read

Eye Disease Biotech Stock Catalyst Watchlist

Originally posted 2/16/23; last updated 4/28/23 Summary: Many exciting eye disease catalysts are coming throughout the year See the table...

Feb 15, 20231 min read

Heart Disease Biotech Stock Catalyst Watchlist

Last updated 4/26/23 Summary: Many exciting heart disease catalysts are coming throughout the year See the table below for some upcoming...

Feb 14, 20231 min read

Ovarian Cancer Biotech Stock Catalyst Watchlist

Last updated 4/25/23 Summary: Many exciting ovarian cancer catalysts are coming throughout the year See the table below for some upcoming...

Feb 13, 20231 min read

Many Exciting Q4 2022 Readouts Coming!

Summary: Q4 2022 quarterly financial reports have started! Many large cap biotechs have already reported, and we expect most of the...

Feb 13, 20231 min read

Mental Health Biotech Stock Catalyst Watchlist

Summary: Many exciting mental health catalysts are coming throughout the year See the table below for some upcoming catalysts and sign up...

Feb 10, 20231 min read

Weekly Biotech Catalyst Watchlist 2/12/23

The ASCO-GU meeting mid Feb kicks off this week! Also have the PDUFA decision for $TVTX with a target date of Friday. See catalysts...

Feb 10, 20231 min read

Biopharma Pulse - 2/6-2/10 Weekly Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Feb 10, 20231 min read

Non-Small Cell Lung Cancer Biotech Stock Catalyst Watchlist

Last updated 4/21/23 Summary: Many exciting non-small cell lung cancer catalysts are coming throughout the year See the table below for...

Feb 9, 20231 min read

Kidney Disease Biotech Stock Catalyst Watchlist

Summary: Many exciting kidney disease catalysts are coming throughout the year See the table below for some upcoming catalysts and sign...

Feb 8, 20231 min read

Colorectal Cancer Biotech Stock Catalyst Watchlist

Summary: Many exciting colorectal cancer catalysts are coming throughout the year See the table below for some upcoming catalysts and...

Feb 7, 20231 min read

Prostate Cancer Biotech Stock Catalyst Watchlist

Summary: Many exciting prostate cancer catalysts are coming throughout the year See the table below for some upcoming catalysts and sign...

Feb 7, 20233 min read

ESPR Detailed Clear Outcomes Data Coming Soon

Summary: ESPR first announced Clear Outcomes Nexletol data in Dec 2022, but only stated the primary endpoint was met They reported that...

Feb 6, 20231 min read

10 Exciting Breast Cancer Catalysts in the First Half of 2023!

Originally posted 2/6/2023; last updated 5/5/2023 Summary: Many exciting breast cancer catalysts are coming throughout the year See the...

Feb 4, 20231 min read

Weekly Biotech Catalyst Watchlist 2/5/23

Already a month into 2023 but still a lot of big events coming this quarter. We have a number of readouts coming including GTHX phase 3...

Feb 3, 20231 min read

Biopharma Pulse - 1/30-2/3 Weekly Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Feb 3, 20231 min read

NASH/Liver Biotech Stock Catalyst Watchlist

Originally published 2/3/23; last updated 3/29/23 Summary: Many exciting liver disease catalysts are coming in the first quarter of the...

Feb 3, 20232 min read

CYTK's Omecamtiv Mecarbil PDUFA and Cardiac Readouts!

Summary: The CYTK PDUFA for Omecamtiv Mecarbil is coming up on February 28 for heart failure with reduced ejection fraction (HErEF) The...

Jump start your biotech due diligence

Get started →

Our platform helps you uncover your next biotech investment opportunity